Who owns the OPTIFOLIN+ trademark?

The OPTIFOLIN+ trademark is owned by Balchem Corporation.

What class is the OPTIFOLIN+ trademark registered in?

The OPTIFOLIN+ trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for OPTIFOLIN+?

The USPTO serial number for OPTIFOLIN+ is 98181769.

What is the registration number for OPTIFOLIN+?

OPTIFOLIN+ is registered under USPTO registration number 7415882.

Sealvo

Home Search: OPTIFOLIN+OPTIFOLIN+ #98181769

Back

Updated Sep 30, 2026·32 searches this week

View on USPTO TSDR Find similar marks

OPT

USPTO Trademark Record

REGISTERED

OPTIFOLIN+

SN 98181769·Reg 7415882·Filed Sep 15, 2023

Owner Balchem Corporation

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

OPTIFOLIN+ (Serial No. 98181769), Registration No. 7415882, is a registered US trademark filed on Sep 15, 2023 by Balchem Corporation. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: June 11, 2030

Conflict Analysis

Full conflict analysis for OPTIFOLIN+ (SN 98181769) against the USPTO database with detailed risk factor explanations. AI-powered — takes ~1-2 min.

Mark Intelligence

OPTIFOLIN+ (Reg. #7415882) is a registered US trademark that has been protecting its owner, Balchem Corporation, since 2023. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Sep 15, 2023

SERIAL

98181769

REG#

7415882

REGISTERED

Jun 11, 2024

Filing Information

StatusREGISTERED

Filing DateSep 15, 2023

Serial Number98181769

Registration No.7415882

Registration DateJun 11, 2024

Status DateJun 11, 2024

Published for OppositionNov 14, 2023

Filing Basis & Declarations

Standard Characters ClaimedUse Application CurrentlyTrademark

International Filings

Madrid Protocol1 filings

This mark has 1 Madrid Protocol filing on record with the USPTO.

1757598

480Sep 24, 2023

Source: USPTO Madrid International Filing Requests

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Nov 06, 2023

First use in commerce: Nov 06, 2023

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

21 events

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Dec 19, 2024

TEAS CHANGE OF OWNER ADDRESS RECEIVED

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Dec 19, 2024

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Dec 19, 2024

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Dec 19, 2024

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Dec 19, 2024

TEAS CHANGE OF CORRESPONDENCE RECEIVED

REGISTERED-PRINCIPAL REGISTER

Jun 11, 2024

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Jun 11, 2024

NOTICE OF REGISTRATION CONFIRMATION EMAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

May 08, 2024

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

May 08, 2024

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

May 03, 2024

CASE ASSIGNED TO INTENT TO USE PARALEGAL

STATEMENT OF USE PROCESSING COMPLETE

May 03, 2024

STATEMENT OF USE PROCESSING COMPLETE

USE AMENDMENT FILED

Apr 12, 2024

USE AMENDMENT FILED

TEAS STATEMENT OF USE RECEIVED

Apr 12, 2024

TEAS STATEMENT OF USE RECEIVED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jan 09, 2024

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Nov 14, 2023

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Nov 14, 2023

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Oct 25, 2023

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

ASSIGNED TO EXAMINER

Oct 11, 2023

ASSIGNED TO EXAMINER

APPROVED FOR PUB - PRINCIPAL REGISTER

Oct 11, 2023

APPROVED FOR PUB - PRINCIPAL REGISTER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Oct 04, 2023

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Sep 19, 2023

NEW APPLICATION ENTERED

Other Marks by Balchem Corporation

Additional USPTO filings from the same owner.

STA

STABILIPRO

98794925

Balchem Corporation

REGISTERED

FLA

FLAVORSHURE

98300035

Balchem Corporation

REGISTERED

REA

REAL FACES OF DAIRY

88088620

Balchem Corporation

REGISTERED

CON

CONFECSHURE

98072011

Balchem Corporation

REGISTERED

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Recently filed and registered marks in the same international class.

OPT

OPTIFOLIN

97753172

Balchem Corporation

ABANDONED

OPT

OPTIFOLIN

85188188

Global Healthcare Focus LLC

ABANDONED

Other Marks by Adam S. Weiss

Additional USPTO filings handled by the same attorney of record.

CLE

CLEARLY BY BEST CHOICE

87582060

REGISTERED

98295593

REGISTERED

DON

DONNA HAY

79011247

REGISTERED

SIN

SINGLE CITY

97772920

REGISTERED

OPTIFOLIN+

Run a conflict check

Other Marks by Balchem Corporation

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Adam S. Weiss

Get pre-filing clearance

Search 15M+ trademarks

Resources

Company